DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

PTC offers high-end computer-assisted design (Creo) and product lifecycle management (Windchill) software as well as augmented reality industrial solutions. Founded in 1985, PTC has 28,000 customers, ...

Earlier this month, PTC announced that HOLON, a BENTELER Group subsidiary, adopted its Windchill+ cloud PLM to develop a Level-4 autonomous EV, while PTC also introduced an AI Engine for its Arena PLM ...

It has been about a month since the last earnings report for PTC Inc. (PTC). Shares have added about 2.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced it has gained FDA approval for SEPHIENCE on Monday. “We are excited to have reached this important milestone for those affected by PKU,” said Matthew B.

A deal between Autodesk and PTC would have made good strategic sense. The industrial software space is rapidly consolidating as the creation of digital threads and loops using data generated by ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In the local tech scene, the ...

Autodesk Inc. is weighing an acquisition of rival engineering-software provider PTC Inc., according to people familiar with the matter. Autodesk has been working with advisers to evaluate a ...

PTC Therapeutics reported a phase 2 win for its Novartis-partnered Huntington's disease candidate. But the readout failed to convince investors, who wiped almost 20% off PTC’s share price amid doubts ...